- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01582659
Outpatient Treatment of Constipation in Children
Outpatient Treatment of Constipation in Children - a Randomized Interventions Study
Constipation is a condition often seen in children. Constipation is often associated with impaired quality of life of the child and of great concern among parents. Despite the fact that both diagnosis and treatment is a simple task, it is often seen that the treatment fails, and many children are referred to a pediatric ward for specialized treatment.
There is currently little research on the subject and treatment is therefore based on expert knowledge rather than scientific research.
The study objective is to identify the most effective and least stressful treatment of children with constipation for both families and the health care system.
The following will be tested:
Does treatment of constipation in children require specialized knowledge and extensive resources or can the treatment be simplified?
The results from this study are expected to form the basis for a evidence based treatment of children with constipation.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kolding, Denmark, 6000
- Line Modin
-
Kolding, Denmark, 6000
- Pediatric department, Kolding Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children between 2 and 16 years and referral to our out patient clinic with either constipation or fecal incontinence.
- Patients must fulfill the Rome III criteria of constipation, which mean they must have at least 2 of the following characteristics: fewer than 3 bowel movements weekly, more than 1 episode of fecal incontinence weekly, large stools in the rectum by digital rectal examination or palpable on abdominal examination, occasional passing of large stools, display of retentive posturing and withholding behavior, and painful defecation.
Exclusion Criteria:
- Children with known organic causes of constipation, including Hirschsprungs disease, spinal and anal congenital abnormalities, previous surgery on the colon, inflammatory bowel disease, allergy and metabolic or endocrine diseases.
- Children receiving drugs known to affect bowel function during a 2 month period before initiation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: No ekstra counseling
Standardized information about childhood constipation is given and the child receives PEG 3350.
No additional follow up appointments are made.
|
|
|
Active Comparator: 2 counseling sessions
Standardized information about childhood constipation is given and the child receives PEG 3350. 2 additional follow up appointments by telephone are made.
|
2 planned telephone counseling sessions are conducted.
Other Names:
|
|
Active Comparator: Web access
Standardized information about childhood constipation is given and the child receives PEG 3350.
No additional follow up appointments are made but the family are given access to a website with information about childhood constipation.
|
Access to a web site with information about childhood constipation similar to the information given at the first visit to the clinic.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment recovery
Time Frame: 1 year
|
Recovery is defined as the child having no symptoms of constipation according to the Rome III chriteria.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Usage of laxative.
Time Frame: 1 year
|
Amount of laxative used during the study periode.
|
1 year
|
|
Telephone contacts
Time Frame: 1 year
|
Number of telephone contacts during the study periode, both planned and unplanned contacts will be noted.
|
1 year
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Marianne Jakobsen, MD, PhD, Kolding
- Study Chair: Poul Erik Kofoed, MD. PHD, Kolding
- Principal Investigator: Line Modin, MD, Kolding
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OutCon
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.